Journal Guide

Bioorganic & Medicinal Chemistry provides an international forum for the publication of full original research papers and critical reviews on molecular interactions in key biological targets such as receptors, channels, enzymes, nucleotides, lipids and saccharides.The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. A special feature will be that colour illustrations will be reproduced at no charge to the author, provided that the Editor agrees that colour is essential to the information content of the illustration in question.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Bioorganic & Medicinal Chemistry Letters presents preliminary experimental or theoretical research results of outstanding significance and timeliness on all aspects of science at the interface of chemistry and biology and on major advances in drug design and development. The journal publishes articles in the form of communications reporting experimental or theoretical results of special interest, and strives to provide maximum dissemination to a large, international audience.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Bioorganic Chemistry publishes accounts of research that provide mechanistic insight inspired by Biology. The guiding principle that the Editorial Board will follow in accepting manuscripts for publication is that the research uses the principles and techniques of organic and physical organic chemistry in attempting to solve some problem of relevance to biology or that are directly inspired by some biological observation.Within this context, manuscripts suitable for submission are ones that deal with such topics as enzymology and biocatalysis (including the study of ribozymes and catalytic antibodies), closely-relevant enzyme models, biosynthesis and combinatorial biosynthesis, and biomimetic synthesis. In addition, the theoretical treatment of any of these topics is appropriate, as is the application of biophysical and analytical techniques to advance our understanding of one of these topics. The Journal publishes regular articles, preliminary communications, reviews and mini-reviews.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Biopharmaceutics & Drug Dispositionpublishes original review articles, short communications, and reports in biopharmaceutics, drug disposition, pharmacokinetics and pharmacodynamics, especially those that have a direct relation to the drug discovery/development and the therapeutic use of drugs. These includes: * animal and human pharmacological studies that focus on therapeutic response. pharmacodynamics, and toxicity related to plasma and tissue concentrations of drugs and their metabolites, * in vitro and in vivo drug absorption, distribution, metabolism, transport, and excretion studies that facilitate investigations related to the use of drugs in man * studies on membrane transport and enzymes, including their regulation and the impact of pharmacogenomics on drug absorption and disposition, * simulation and modeling in drug discovery and development * theoretical treatises * includes themed issues and reviews and exclude manuscripts on * bioavailability studies reporting only on simple PK parameters such as Cmax, tmax and t1/2 without mechanistic interpretation * analytical methods Reports must contain current citation of the literature and convey new information. Biopharmaceutics & Drug Disposition is one of the top accessed and cited journals in the field, as a result of the high quality papers published in the journal, and is marketed by Wiley Blackwell across the world.

Biotechnology and Applied Biochemistry has been published continuously since its creation in 1986 (previous to that date it was called the Journal of Applied Biochemistry and was published from 1979 to 1985). Today it enjoys a superb track record, attracting distinguished authors from academia and industry from all over the world, reflecting its international status. Biotechnology and Applied Biochemistry is now published bi-monthly by Wiley-Blackwell, confirming the journal's dedication to change and commitment to rapid publication of high-quality, cutting-edge research at the interface between life sciences and their translation. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences. Promising advances in life sciences are leading to the identification of the molecular sources of disease and the creation of new generation of medicines for diseases for which there are currently either no therapies or inadequate treatments. Therapeutic proteins and antibodies are already having a significant impact in treatment of disease. Therapeutic genes and viruses promise to have an even bigger impact on human healthcare. DNA vaccine and gene-therapy are under intense development and new research areas such as tissue engineering, stem-cell therapeutics, germ-line therapy and regenerative medicines are expected to create a new wave of medicines that will make today's treatment of diseases look distinctively primitive. All this provides major challenges to life scientists and engineers engaged in discoveries and their translation to practical outcomes. Turning a new discovery into a successful application has become a highly integrated, multidisciplinary activity, and Biotechnology and Applied Biochemistry is uniquely placed to provide an international forum for the dissemination of information and discussion by researchers working across the many subject groups. The journal welcomes submissions of original articles on the following topics: nucleic acids and proteins engineering and purification; genes peptides and proteins therapy; biomaterials; biological modeling; stem cells and tissue engineering; bio-imaging; bio-sensors; biotechnology of food and natural compounds. Original papers and reviews as well as special issues can be also invited by the Editorial Board. Papers are easily submitted online at: http://mc.manuscriptcentral.com/bab.

Reports on all aspects of drug action in humansOriginal papers. reviews. editorials. letters. book reviewsNorth American. European. Australasian EditorsSpecial supplements on new drugsOpen-access after 12 monthsOnline submission through ScholarOne Manuscripts Published on behalf of the British Pharmacological Society Aims and Scope Published on behalf of the British Pharmacological Society. theBritish Journal of Clinical Pharmacologycontains papers and reports on all aspects of drug action in humans: invited review articles. original papers. short communications and correspondence. The Journal enjoys a wide readership. bridging the gap between the medical profession. clinical research and the pharmaceutical industry. Proceedings of the meetings of the Clinical Section of the British Pharmacological Society are published in abstract form. and supplements containing information on new methods. new drugs and new approaches to treatment are supplied free of charge. All editorials now available to access free online. Clickhere to access now! Readership The journal contains research and review articles on all aspects of drug action in humans. together with abstracts of clinical proceedings of the Society. The journal is recognized as one of the leading publications in its field. The readership consists of clinical pharmacologists in academic and NHS posts. pharmacologists. pharmacists. physicians as well as scientists in the pharmaceutical industry. The readership reflects the journal"s role as a bridge between the medical professions. clinical research and the pharmaceutical industry.

2009 Impact Factor: 5.204* BJPis the highest ranked general pharmacology research journal. now ranked 19th in the ISI Pharmacology and Pharmacy category* * Thomson Reuters Science Citation Index 2009 Aims and Scope TheBritish Journal of Pharmacology(BJP) is a broad-based journal giving leading international coverage of all aspects of experimental pharmacology. Its scope includes: Anti-infective drugs Biopharmaceuticals Cancer pharmacology Cardiovascular pharmacology Drug discovery Drug safety and toxicology Endocrine and metabolic pharmacology Gastrointestinal pharmacology Genitourinary and renal pharmacology Immunopharmacology and Inflammation Molecular and cellular mechanisms Neuropharmacology Pharmacokinetics and drug metabolism Respiratory system pharmacology Methods and techniques Social impact of pharmacology Readership Pharmacologists; toxicologists; pharmaceutical researchers; medicinal chemists; molecular biologists; physiologists; neuroscientists; target discovery and drug discovery researchers. pharmacists; clinicians. Keywords British Journal of Pharmacology. BJP. journal. pharmacology. pharmacological. drugs. therapeutics. medicinal chemistry. pharmaceutical medicine. experimental pharmacology. translational research. biopharmaceuticals. drug discovery. drug safety. pharmacokinetics and drug metabolism. toxicology. neuropharmacology. cardiovascular pharmacology. respiratory pharmacology. immunopharmacology. cancer. endocrine pharmacology. GRAC. receptors. channels. transporters. G-protein coupled receptors. antagonist. agonist. drug targets. target discovery. drug design. pharma. pharmaceutical research. British Pharmacological Society.

The Bulletin of Environmental Contamination and Toxicology provides rapid publication of peer-reviewed articles describing significant advances and discoveries in the fields of air, soil, water, and food contamination and pollution as well as articles on methodology and other disciplines concerned with the introduction, presence and effects of toxicants in the total environment. With its high standards of scientific quality and clarity, the Bulletin provides a meeting ground for research workers who daily encounter problems related to the contamination of our environment and who welcome opportunities to share in new discoveries as soon as they are made.

The Bulletin of Mathematical Biology is devoted to research at the junction of computational, theoretical and experimental biology. Articles offer a combination of theory and experiment, documenting theoretical advances with clear exposition of how they further biological understanding. Its aim is to be of major interest to theorists and experimental biologists alike.The Bulletin of mathematical biology also invites submissions of review articles which offer an in-depth treatment of an emerging research area, or a significant recent development, in the general area of computational, theoretical and mathematical biology. Those interested in writing such a review article should contact James Sneyd at sneyd@math.auckland.ac.nz This is the official journal of the Society for Mathematical Biology.

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.

Published since 1929, this monthly journal reports current research in all aspects of physiology, nutrition, pharmacology, and toxicology, contributed by recognized experts and scientists. It publishes symposium reviews and award lectures and occasionally dedicates entire issues or portions of issues to subjects of special interest to its international readership. The journal periodically publishes a “Made In Canada” special section that features invited review articles from internationally recognized scientists who have received some of their training in Canada.

Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.

Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.

Cancer Nanotechnology is devoted for applications of nanotechnology to oncology. This journal publishes important original studies in the following areas:

· Basic research on the design and development of nanoparticles for oncology
· Interactions of nanoparticles with cancer cells
· Nanodrug delivery system for prevention and therapy of cancer
· Nanoparticles mediated cancer diagnostic systems
· Nanoparticles for therapy of human cancer
· Clinical trials evaluating nanoceuticals

Cancer Biotherapy and Radiopharmaceuticals is a peer-reviewed journal covering cutting-edge biotherapy and innovative investigations of methods to improve cancer therapy. Includes more selective delivery of drugs, biologicals, radiopharmaceuticals, and other agents, and advances in delivery instrumentation and technology, with the aim of increasing efficacy of therapy, decreasing toxicity, and/or improving convenience of therapy.Topics include:• Pre-targeted cancer therapy• Clinical trials in cancer research• Antibody therapy and imaging• Tumor cell vaccines• Radioimmunotherapy• T-cell therapy• Molecular targeted therapy and imaging• Drug resistance.

Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents. Each issue contains a series of timely in-depth reviews, original research articles and drug clinical trial studies written by leaders in the field covering a range of current topics in Cardiovascular & Hematological medicinal chemistry.

Designed to objectively cover the world of cardiovascular pharmacology and therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field. Homing in on the most exciting work being done on new therapeutic agents, heart failure, hypertension and acute myocardial infarction, among others, Cardiovascular Drugs and Therapy is an authoritative source of current and relevant news that is indispensable for cardiologists seeking to best serve their patients.

Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Current Contents and Index Medicus, the regular articles and frequent free supplementary issues equip you with an up-to-date source defined by the need for accurate information on an ever-changing field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of

Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) focuses on extensive reviews and original articles on the treatment of cardiovascular disease. The main focus of the journal is on articles in cardiovascular pharmacology and clinical pharmacology and clinical trials of new or potential cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies and pharmacoepidemiology are also encouraged.

Cardiovascular Toxicology is the only journal dedicated to publishing contemporary issues, timely reviews, and experimental and clinical data on the molecular therapy of cardiovascular disease. CT publishes papers that will elucidate the effects, molecular mechanisms, and signaling pathways of environmental toxicants on the cardiovascular system. Also covered are the detrimental effects of new cardiovascular drugs, and cardiovascular effects of non-cardiovascular drugs, anti-cancer chemotherapy, and gene therapy. In addition, Cardiovascular Toxicology reports safety and toxicological data on new cardiovascular and non-cardiovascular drugs. This is a unique journal in which these data can be scrutinized separately from efficacy.